ABIONYX Pharma Market Cap

ABIONYX Pharma has a market cap or net worth of €128.41 million as of April 24, 2026. Its market cap has increased by 219.23% in one year.

Market Cap

128.41M

Enterprise Value

129.16M

Revenue

4.10M

Ranking

n/a

PE Ratio

n/a

Stock Price

€3.62

Market Cap Chart

Since March 30, 2015, ABIONYX Pharma's market cap has decreased from 214.16M to 128.41M, a decrease of -40.04%. That is a compound annual growth rate of -4.51%.

Market Cap History

Date	Market Cap	% Change
Apr 23, 2026	128.41M	-3.83%
Dec 31, 2025	133.53M	223.58%
Dec 31, 2024	41.27M	-0.54%
Dec 29, 2023	41.49M	-14.37%
Dec 30, 2022	48.45M	-28.38%
Dec 31, 2021	67.65M	178.53%
Dec 31, 2020	Upgrade Pro	Upgrade Pro
Dec 31, 2019	Upgrade Pro	Upgrade Pro
Dec 31, 2018	Upgrade Pro	Upgrade Pro
Dec 29, 2017	Upgrade Pro	Upgrade Pro
Dec 30, 2016	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Genfit	408.32M
Cellectis	242.45M
Transgene	207.33M
Sensorion	197.40M
Innate Pharma	108.28M
MaaT Pharma	99.87M
Adocia	92.48M
Valerio Therapeutics Société anonyme	74.30M

Market Cap Rankings